Filtra per Last updated date ScegliereDopoPrimaFrom - To Data Data di conclusione Questa settimana Questo mese Ultima settimana Ultimo mese Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filtra Risultati (3786) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 October 2021 15 Ottobre 2021 News Human Medicines Referrals EMA starts rolling review of Evusheld (tixagevimab and cilgavimab) 14 Ottobre 2021 News Human COVID-19 Medicines EMA ends rolling review of CVnCoV COVID-19 vaccine following withdrawal by CureVac AG 12 Ottobre 2021 News Human COVID-19 Vaccines A global approach to regulatory flexibility to increase manufacturing capacity during COVID-19 12 Ottobre 2021 News Human COVID-19 Medicines Vaccines EMA receives application for marketing authorisation for Ronapreve (casirivimab / imdevimab) for treatment and prevention of COVID-19 11 Ottobre 2021 News Human COVID-19 Paediatrics Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 5-7 October 2021 8 Ottobre 2021 News Veterinary Medicines Highlights of Management Board – October 2021 meeting 8 Ottobre 2021 News Corporate Additional manufacturing site for COVID-19 Vaccine Janssen 7 Ottobre 2021 News Human COVID-19 Comirnaty and Spikevax: EMA recommendations on extra doses and boosters 4 Ottobre 2021 News Human COVID-19 EMA receives application for marketing authorisation for Regkirona (regdanvimab) for treating patients with COVID-19 4 Ottobre 2021 News Human COVID-19 Medicines 1 … 52 53 54 55 56 Page 56 of 379 57 58 59 60 … 379
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 October 2021 15 Ottobre 2021 News Human Medicines Referrals
EMA starts rolling review of Evusheld (tixagevimab and cilgavimab) 14 Ottobre 2021 News Human COVID-19 Medicines
EMA ends rolling review of CVnCoV COVID-19 vaccine following withdrawal by CureVac AG 12 Ottobre 2021 News Human COVID-19 Vaccines
A global approach to regulatory flexibility to increase manufacturing capacity during COVID-19 12 Ottobre 2021 News Human COVID-19 Medicines Vaccines
EMA receives application for marketing authorisation for Ronapreve (casirivimab / imdevimab) for treatment and prevention of COVID-19 11 Ottobre 2021 News Human COVID-19 Paediatrics
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 5-7 October 2021 8 Ottobre 2021 News Veterinary Medicines
Comirnaty and Spikevax: EMA recommendations on extra doses and boosters 4 Ottobre 2021 News Human COVID-19
EMA receives application for marketing authorisation for Regkirona (regdanvimab) for treating patients with COVID-19 4 Ottobre 2021 News Human COVID-19 Medicines